{"title":"Informations de la Ligue Suisse contre l‘Epilepsie","authors":"","doi":"10.1007/s10309-023-00635-8","DOIUrl":"https://doi.org/10.1007/s10309-023-00635-8","url":null,"abstract":"","PeriodicalId":500484,"journal":{"name":"Clinical Epileptology","volume":"10 6","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135714345","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Mitteilungen der Deutschen Gesellschaft für Epileptologie e. V.","authors":"","doi":"10.1007/s10309-023-00641-w","DOIUrl":"https://doi.org/10.1007/s10309-023-00641-w","url":null,"abstract":"","PeriodicalId":500484,"journal":{"name":"Clinical Epileptology","volume":"1 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135715110","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Mitteilungen der Österreichischen Gesellschaft für Epileptologie","authors":"","doi":"10.1007/s10309-023-00637-6","DOIUrl":"https://doi.org/10.1007/s10309-023-00637-6","url":null,"abstract":"","PeriodicalId":500484,"journal":{"name":"Clinical Epileptology","volume":"70 6","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135715466","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Main topic of this issue: “epileptological emergencies”","authors":"Edda Haberlandt, Stephan Rüegg","doi":"10.1007/s10309-023-00625-w","DOIUrl":"https://doi.org/10.1007/s10309-023-00625-w","url":null,"abstract":"","PeriodicalId":500484,"journal":{"name":"Clinical Epileptology","volume":"1 2","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135715109","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Justus M. Zemberi, Barry E. Gidal, Robert J. Kotloski
{"title":"Seizure clusters: diagnostic and therapeutic advances","authors":"Justus M. Zemberi, Barry E. Gidal, Robert J. Kotloski","doi":"10.1007/s10309-023-00640-x","DOIUrl":"https://doi.org/10.1007/s10309-023-00640-x","url":null,"abstract":"","PeriodicalId":500484,"journal":{"name":"Clinical Epileptology","volume":"69 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-10-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135729278","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Übersicht über erstmaliges Auftreten eines therapierefraktären Status epilepticus: aktuelle Konzepte, Diagnose und Behandlung","authors":"Ronny Wickström","doi":"10.1007/s10309-023-00632-x","DOIUrl":"https://doi.org/10.1007/s10309-023-00632-x","url":null,"abstract":"Abstract New-onset refractory status epilepticus (NORSE) is a rare and devastating condition presenting with refractory status epilepticus and often evolving into super-refractory status epilepticus. The poor outcome with a significant mortality rate and a high rate of morbidity among survivors of NORSE warrants awareness and early identification of the condition so as to initiate appropriate investigations and management. Although the pathophysiological mechanisms are unknown, inflammatory mechanisms including activation of innate immunity are likely involved. Treatment should therefore include aggressive escalation of antiseizure medications followed by early initiation of a ketogenic diet and immunomodulation. First-line immunotherapy should be initiated within 72 h of seizure onset, with a ketogenic diet and second-line immunomodulation being started in the first week if seizures remain. This article aims to review current knowledge on NORSE and to highlight specific areas including recent consensus definitions and Delphi-based recommendations as well as open registries for future research.","PeriodicalId":500484,"journal":{"name":"Clinical Epileptology","volume":"25 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-10-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135994418","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Ein Blended-Learning-Ansatz für die klinische Epileptologie","authors":"S. Claß, R. von Wrede, T. Baumgartner, R. Surges","doi":"10.1007/s10309-023-00628-7","DOIUrl":"https://doi.org/10.1007/s10309-023-00628-7","url":null,"abstract":"","PeriodicalId":500484,"journal":{"name":"Clinical Epileptology","volume":"50 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-10-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135350898","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Peter Borusiak, Thomas Bast, Edda Haberlandt, Gert Wiegand
{"title":"Epilepsy monitoring devices in children and adolescents","authors":"Peter Borusiak, Thomas Bast, Edda Haberlandt, Gert Wiegand","doi":"10.1007/s10309-023-00630-z","DOIUrl":"https://doi.org/10.1007/s10309-023-00630-z","url":null,"abstract":"Zusammenfassung Hintergrund Viele Eltern der Kinder und Jugendlichen mit Epilepsien wünschen eine Überwachung insbesondere von nächtlichen Anfällen. Daten zu den einzelnen Geräten stammen überwiegend aus einem klinischen Setting an Erwachsenen. Alltagsbezogene Daten für Kinder und Jugendliche fehlen. Ziel der Arbeit Es erfolgte die Sammlung von alltagsbezogenen Informationen und Einschätzungen über den Einsatz verschiedener Überwachungsgeräte bei Kindern und Jugendlichen im häuslichen Setting. Material und Methoden In Zusammenarbeit mit dem Elternverband (e.b.e.) erfolgte vom 01.03.2023 bis 16.04.2023 eine Querschnittuntersuchung via eine webbasierte Umfrage mittels SoSci-Survey. Ergebnisse Für die Altersgruppe < 18 Jahre lagen 153 auswertbare Datensätze vor. Hiervon war bei 129 Teilnehmenden zumindest über einen Zeitraum ein Überwachungsgerät im Einsatz. Die Gruppen mit oder ohne Anfallsüberwachung unterschieden sich nicht hinsichtlich demografischer und epilepsiebezogener Faktoren. Es kam eine Vielzahl von Geräten quer durch alle Altersgruppen zum Einsatz, ohne dass eine eindeutige Präferenz erkennbar war. Die am häufigsten verwendeten Geräte waren NightWatch® ( N = 39), VitaGuard® 3100/310 ( N = 18) und die verschiedenen Epi-Care®-Modelle ( N = 16). Im Elternurteil wurden Benutzerfreundlichkeit, Sicherheit und Zuverlässigkeit und Eignung für die Anfallsüberwachung benotet, wobei sich kein klares und eindeutiges Bild ergab. Diskussion Letztendlich kann auch auf Basis unserer Daten keine allgemeingültige Empfehlung für oder gegen ein bestimmtes Gerät ausgesprochen werden. Der Bericht hilft Patient*innen und ihren Ärzt*innen, einen Einblick in den Alltag mit nächtlicher Überwachung zu bekommen, und kann dazu beitragen, sich ein eigenes Bild je nach Präferenzen zu machen.","PeriodicalId":500484,"journal":{"name":"Clinical Epileptology","volume":"301 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-10-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"134975949","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
